Air Purifier Use and Respiratory Health in COPD Patients
Recruiting · NCT07505602 · Interventional (participants receive a specific treatment) · Lead sponsor: Fudan University
View the official record on ClinicalTrials.gov →Interventions studied
Using air purifiers with high-efficiency particulate air (HEPA) and carbon filtersUsing air purifiers with non-functional filtration system
What this trial is about
This randomized, double-blind, parallel-controlled trial aims to evaluate the effects of an indoor air purifier intervention on respiratory health in patients with Chronic Obstructive Pulmonary Disease (COPD).
Who can take part
Age range
50 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age between 50 and 80 years old
- Physician diagnosis of COPD
- Living in Shanghai during the intervention period
- Subjects who have no plans to change homes during the intervention period
- Non-smokers and former smokers
Exclusion criteria
- Subjects living in a location other than home
- Subjects with a history of alcohol abuse
- Subjects with other chronic lung diseases, such as active tuberculosis, pulmonary fibrosis, cystic fibrosis, or alpha-1 antitrypsin deficiency
- Subjects with a history of thoracic surgery
- Subjects with a history of malignant tumors, such as lung cancer, liver cancer, or gastric cancer
- Subjects with diagnosed chronic hepatic or renal insufficiency, such as liver cirrhosis, chronic viral hepatitis, or autoimmune liver disease
- Subjects with acute myocardial infarction or unstable arrhythmia diagnosed within the past 6 weeks
- Subjects currently participating in other interventional studies
Where it is running
1 location listed.
- School of Public Health, Fudan University - Shanghai, China